Assessment of estrogen and progestin therapy in gynecology and obstetrics.
D000152:Acne Vulgaris / Q000188:drug therapy; D001827:Body Height / Q000187:drug effects; D055598:Chemical Phenomena; D002621:Chemistry; D004412:Dysmenorrhea / Q000188:drug therapy; D004714:Endometrial Hyperplasia / Q000188:drug therapy; D045166:Estradiol Congeners / Q000378:metabolism; D004967:Estrogens / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D005069:Evaluation Studies as Topic; D005260:Female; D005831:Genital Diseases, Female / Q000188:drug therapy*; D006628:Hirsutism / Q000188:drug therapy; D006801:Humans; D007246:Infertility / Q000188:drug therapy; D008297:Male; D008593:Menopause / Q000187:drug effects; D011247:Pregnancy / Q000187:drug effects*; D011372:Progestins / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D011629:Puberty, Precocious / Q000188:drug therapy; D014424:Turner Syndrome / Q000188:drug therapy; D014592:Uterine Hemorrhage / Q000188:drug therapy; D014594:Uterine Neoplasms / Q000188:drug therapy; D014599:Uterus / Q000187:drug effects; D014621:Vagina / Q000187:drug effects
D045166:Estradiol Congeners; D004967:Estrogens; D011372:Progestins